Applied Therapeutics, Inc. (APLT) Misses Q3 EPS by 23c

Applied Therapeutics, Inc. (NASDAQ: APLT) reported Q3 EPS of ($0.47), $0.23 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Applied Therapeutics, Inc. (APLT) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• CarMax (KMX) PT Raised to $47 at Morgan Stanley
• Oppenheimer Starts Viatris (VTRS) at Outperform